ClinicalTrials.Veeva

Menu

Radiological Evaluation of Sarcopenia in Patient Received Chemotherapy

A

Assiut University

Status

Not yet enrolling

Conditions

Sarcopenia

Study type

Observational

Funder types

Other

Identifiers

NCT06166134
Us and CT in sarcopenia

Details and patient eligibility

About

Radiological evaluation of sarcopenia in patients receiving chemotherapy

Full description

Evaluation of muscle mass by using sonoelastography and computed tomography

Enrollment

72 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • all cancer patients receiving chemotherapy referred to radiodiagnosis department for routine examination Patients must be between 18 and

Exclusion criteria

  • Previous or current history of any musculoskeletal or neurological disorder including strokes.
  • Systemic atrophy affecting CNS ( Huntington disease ,hereditary ataxia ,spinal muscular disorder and related syndromes ,post polio syndrome )
  • Central nervous system demyelinating disease ( Multiple sclerosis , acute disseminated demyelinated syndromes..
  • Corticosteroids undertaken currently or for the past 3 years with doses >5mg/day.

Trial contacts and locations

0

Loading...

Central trial contact

Doaa Maher ebied Maher, Resident; Hasan ibrahim Megally, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems